These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16218478

  • 1. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y.
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [Abstract] [Full Text] [Related]

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 3. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 4. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K, Lopez LR, Matsuura E.
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [Abstract] [Full Text] [Related]

  • 5. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR.
    Clin Dev Immunol; 2003 Jun; 10(2-4):203-11. PubMed ID: 14768953
    [Abstract] [Full Text] [Related]

  • 6. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E, Kobayashi K, Hurley BL, Lopez LR.
    Lupus; 2006 Jun; 15(7):478-83. PubMed ID: 16898186
    [Abstract] [Full Text] [Related]

  • 7. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 8. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I.
    Lupus; 2006 Nov; 15(2):80-6. PubMed ID: 16539278
    [Abstract] [Full Text] [Related]

  • 9. Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?
    Matsuura E, Lopez LR.
    Clin Dev Immunol; 2004 Jun; 11(2):103-11. PubMed ID: 15330445
    [Abstract] [Full Text] [Related]

  • 10. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR, Kobayashi K, Matsunami Y, Matsuura E.
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [Abstract] [Full Text] [Related]

  • 11. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR.
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V, Bison E, Ruffatti A, Iliceto S.
    Thromb Res; 2008 Mar; 122(4):556-9. PubMed ID: 18328538
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune-mediated atherothrombosis.
    Matsuura E, Lopez LR.
    Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
    [Abstract] [Full Text] [Related]

  • 14. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI, Amengual O, Atsumi T, Khamashta MA, Tinahones FJ, Hughes GR.
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [Abstract] [Full Text] [Related]

  • 15. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E.
    Lupus; 2007 Aug; 16(12):929-38. PubMed ID: 18042586
    [Abstract] [Full Text] [Related]

  • 16. Atherosclerosis in autoimmune diseases.
    Matsuura E, Kobayashi K, Lopez LR.
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [Abstract] [Full Text] [Related]

  • 17. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N, Ghirardello A, Iaccarino L, Zampieri S, Rampudda ME, Atzeni F, Sarzi-Puttini P, Shoenfeld Y, Doria A.
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [Abstract] [Full Text] [Related]

  • 18. Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease.
    Berger JS, Rockman CB, Guyer KE, Lopez LR.
    J Immunol Res; 2014 Nov; 2014():234316. PubMed ID: 25405208
    [Abstract] [Full Text] [Related]

  • 19. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
    Zhang X, Xie Y, Zhou H, Xu Y, Liu J, Xie H, Yan J.
    J Atheroscler Thromb; 2014 Nov; 21(11):1140-51. PubMed ID: 24998486
    [Abstract] [Full Text] [Related]

  • 20. Autoantibody-mediated atherosclerosis.
    Matsuura E, Kobayashi K, Koike T, Shoenfeld Y.
    Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.